Skip to content
All compound profiles

EVIDENCE PROFILE / PUBLISHED

Selank

Selank is a synthetic heptapeptide related to a tuftsin fragment; free peptide and acetate should not be assumed equivalent. A Russian-language randomized report evaluated generalized anxiety disorder and neurasthenia, but the accessible evidence base is limited and lacks broad independent replication.

Aliases reviewed
Selank acetate, TP-7
Sources checked
2026-09-15
Editorial status
published

Evidence at a glance

Human
LimitedOne randomized report from regional literature, with little independent replication.
Animal/cell
Not rated
Approved medicine
None foundScope: the Canadian and U.S. sources reviewed.

Summarises how much research the profile's sources report, and of what kind. It is not a verdict on the compound or on any catalogue material.

PREPPY BOY ASKS

“A familiar name can hide a different molecule, fragment, formulation, or evidence story.”

The catalogue name is a starting point, not proof of formulation or identity. Research has examined anxiety-related outcomes, immune-neural signaling, and gene-expression effects.

Identity

Selank is a synthetic heptapeptide related to a tuftsin fragment; free peptide and acetate should not be assumed equivalent.

Biological mechanism or research interest

Research has examined anxiety-related outcomes, immune-neural signaling, and gene-expression effects.

Verified approved human uses

No Canadian or U.S. approved use was verified in the reviewed sources.

Investigational human evidence

A Russian-language randomized report evaluated generalized anxiety disorder and neurasthenia, but the accessible evidence base is limited and lacks broad independent replication.

Rapid anxiolysis, cognitive enhancement, and absence of dependence are not established for an unspecified catalogue material.

Human versus animal or cell evidence

Many proposed mechanisms come from animal and laboratory work rather than robust human outcome trials.

Limitations and known risks

FDA reports inadequate human safety information for selank acetate; formulation, immunogenicity, impurities, interactions, and long-term effects remain uncertain.

What this profile is—and is not

Concise source review published with formulation, jurisdiction, and evidence-strength limits; recheck before material revision.

This is sourced education, not medical advice or a personal-use recommendation. It does not validate the identity, purity, sterility, safety, or effectiveness of a catalogue material.